Skip to Main Content

Paper Details

Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.
BMC Cancer
7
2022
Circulating cell-free DNA, benign, benign tumours, breast cancer, cancer, cell-free DNA, cell-free tumour DNA, cfDNA, cfDNA fragments, ctDNA, di, genome, germline, germline DNA, patients, plasma, plasma DNA samples, plasma samples, sCNAs, somatic cfDNA variants, tumour, tumour DNA, tumour cells
Author NameAffiliation
Sunil R LakhaniCentre for Clinical Research, The University of Queensland
Sunil R LakhaniThe Royal Brisbane & Women's Hospital
Sunil R LakhaniCentre for Clinical Research, The University of Queensland
Sunil R LakhaniThe Royal Brisbane & Women's Hospital
Katia NonesQIMR Berghofer Medical Research Institute
Katia NonesQIMR Berghofer Medical Research Institute
Peter T SimpsonCentre for Clinical Research, The University of Queensland
Peter T SimpsonCentre for Clinical Research, The University of Queensland
Lachlan J M CoinInstitute for Molecular Bioscience, University of Queensland
Lachlan J M CoinThe University of Melbourne
Lachlan J M CoinThe University of Melbourne
Lachlan J M CoinImperial College London
Lachlan J M CoinInstitute for Molecular Bioscience, University of Queensland
Lachlan J M CoinThe University of Melbourne
Lachlan J M CoinThe University of Melbourne
Lachlan J M CoinImperial College London
  • 1 - 16

Datasets

Release 1.2